The use of substituted azetidinone compounds for the treatment of sitosterolemia

Details for Australian Patent Application No. 2005246926 (hide)

International Classifications

Event Publications

12 January 2006 Complete Application Filed

19 January 2006 Application Open to Public Inspection

Published as AU-B-2005246926

23 March 2006 Application with amended filing dates

Schering Corporation The filing date has been amended to 23.01.2006

28 February 2008 Application Accepted

Published as AU-B-2005246926

26 June 2008 Standard Patent Sealed

11 October 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.